Evidence map›Paper›PMID 36839283›Full record

SynthesisNutrients2023

Association between Alcohol Intake and Prostate Cancer Mortality and Survival.

Oriana D'Ecclesiis, Elisa Pastore, Sara Gandini, Saverio Caini, Giulia Marvaso, Barbara A Jereczek-Fossa, Giulia Corrao, Sara Raimondi, Federica Bellerba, Silvia Ciceri and 6 more

Open access · goldAbstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Oriana D'EcclesiisDepartment of Experimental Oncology, European Institute of Oncology, IRCCS, 20139 Milan, Italy.
Elisa PastoreInstitute for Cancer Research, Prevention, and Clinical Network (ISPRO), Via Cosimo il Vecchio 2, 50139 Florence, Italy.ORCID 0000-0001-6994-434X
Sara GandiniDepartment of Experimental Oncology, European Institute of Oncology, IRCCS, 20139 Milan, Italy.ORCID 0000-0002-1348-4548
Saverio CainiInstitute for Cancer Research, Prevention, and Clinical Network (ISPRO), Via Cosimo il Vecchio 2, 50139 Florence, Italy.ORCID 0000-0002-2262-1102
Giulia MarvasoDepartment of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.ORCID 0000-0002-5339-8038
Barbara A Jereczek-FossaDepartment of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.
Giulia CorraoDivision of Radiation Oncology, European Institute of Oncology, IRCCS, 20141 Milan, Italy.ORCID 0000-0002-5757-6073
Sara RaimondiDepartment of Experimental Oncology, European Institute of Oncology, IRCCS, 20139 Milan, Italy.ORCID 0000-0003-4673-9049
Federica BellerbaDepartment of Experimental Oncology, European Institute of Oncology, IRCCS, 20139 Milan, Italy.ORCID 0000-0002-5956-4340
Silvia CiceriDivision of Epidemiology and Biostatistics, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
Marialetizia LatellaDivision of Epidemiology and Biostatistics, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
Nora de Bonfioli CavalcabòInstitute for Cancer Research, Prevention, and Clinical Network (ISPRO), Via Cosimo il Vecchio 2, 50139 Florence, Italy.ORCID 0000-0003-1863-2009
Benedetta BendinelliInstitute for Cancer Research, Prevention, and Clinical Network (ISPRO), Via Cosimo il Vecchio 2, 50139 Florence, Italy.
Calogero SaievaInstitute for Cancer Research, Prevention, and Clinical Network (ISPRO), Via Cosimo il Vecchio 2, 50139 Florence, Italy.ORCID 0000-0002-0117-1608
Miriam FontanaInstitute for Cancer Research, Prevention, and Clinical Network (ISPRO), Via Cosimo il Vecchio 2, 50139 Florence, Italy.ORCID 0000-0001-7982-0287
Patrizia GnagnarellaDivision of Epidemiology and Biostatistics, European Institute of Oncology, IRCCS, 20141 Milan, Italy.ORCID 0000-0002-0560-4706
European Institute of Oncology · ITUniversity of Milan · IT

Funding

Governo Italiano RF-2019-12368771
6 · The paper itself

Abstract

We conducted a systematic review and meta-analysis to investigate the role of alcohol consumption with the prognosis of prostate cancer (PCa). Published reports were gathered on 15 October 2022, from PUBMED/MEDLINE and EMBASE. We found 19 independent eligible studies on the association between consumption of alcoholic beverages and the risk of fatal PCa (n = 5), PCa mortality (n = 5) in healthy subjects, and PCa patients' survival (n = 7) or surrogates thereof (n = 2). We used random effects meta-analysis to obtain a summary risk estimate (SRE) and 95% confidence intervals (95%CI) for incidence of fatal PCa and PCa mortality. The meta-analysis revealed no association between alcohol consumption and fatal prostate cancer incidence risk in healthy subjects with an indication for publication bias, but omitting the study that mainly increased the between-study heterogeneity, the SRE becomes significant (SRE 1.33, 95%CI 1.12-1.58), and the heterogeneity disappeared (

Indexed as

Alcohol DrinkingProstatic NeoplasmsHumansIncidenceMalePrognosisProstatealcoholMeta-analysismortalityprostate cancersurvival

Identifiers

PMID36839283
PMCPMC9965886
OpenAlexW4320497512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.